ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 964,97
0,64%
Dow Jones
38 225,66
0,85%
DAX
17 988,80
0,46%
Brent Oil
83,83
0,24%
Bitcoin
59 316,48
0,33%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. InMed Pharmaceuticals Inc (INM)

  7. InMed Pharmaceuticals Inc (INM) Actualités

INM InMed Pharmaceuticals Inc

0,2595
-0,0044 (-1,67%)
Avant marché
Dernière mise à jour : 10:47:44
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
InMed Pharmaceuticals Inc INM NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0044 -1,67% 0,2595 10:47:44
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,2639
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
05/3/202421:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202421:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202421:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202421:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/2/202419:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202420:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/2/202418:34EDGAR2Form 8-K - Current report
19/1/202420:33EDGAR2Form 8-K - Current report
16/1/202420:12EDGAR2Form 8-K - Current report
26/12/202319:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202323:21EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
06/12/202315:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202320:50EDGAR2Form 8-K - Current report
14/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202323:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/11/202323:05EDGAR2Form S-1 - General form for registration of securities under..
02/11/202319:56EDGAR2Form 8-K - Current report
27/10/202322:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/10/202322:04EDGAR2Form DEF 14A - Other definitive proxy statements
24/10/202322:18EDGAR2Form 8-K - Current report
29/9/202323:18EDGAR2Form 8-K - Current report
29/9/202317:43EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/9/202317:30EDGAR2Form NT 10-K - Notification of inability to timely file Form..
25/9/202322:12EDGAR2Form 8-K - Current report
31/8/202323:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202322:26EDGAR2Form 8-K - Current report
20/7/202320:18EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
INM
InMed Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés